Report from the Technical University of Munich on rnatics as one of its most promising startups

A spray to protect against lung damage from Covid-19

German Ministry of Science funds development of Covid-19 drug

rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases. The Federal Ministry of Education and Research (BMBF) is providing 7 million euros in funding to support the development of the drug. The team is using a substance that inhibits the inflammation-promoting microRNA. The therapy is expected to be efficacious in current and future mutations of SARS-CoV2.

Read the full article